Case Reports
doi: 10.1128/AAC.00309-07.
Epub 2007 Apr 9.
SME-2-producing Serratia marcescens isolate from Switzerland
- PMID: 17420208
- PMCID: PMC1891368
- DOI: 10.1128/AAC.00309-07
Item in Clipboard
Case Reports
SME-2-producing Serratia marcescens isolate from Switzerland
Antimicrob Agents Chemother.
2007 Jun.
No abstract available
Similar articles
-
SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.Antimicrob Agents Chemother. 2006 Oct;50(10):3485-7. doi: 10.1128/AAC.00363-06. Antimicrob Agents Chemother. 2006. PMID: 17005839 Free PMC article.
-
Occurrence of an SME-2-producing Serratia marcescens isolate in Canada.Int J Antimicrob Agents. 2008 Feb;31(2):181-2. doi: 10.1016/j.ijantimicag.2007.10.007. Epub 2007 Dec 20. Int J Antimicrob Agents. 2008. PMID: 18083009 No abstract available.
-
Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.Microbiol Res. 2007;162(1):46-52. doi: 10.1016/j.micres.2006.06.005. Epub 2006 Jul 27. Microbiol Res. 2007. PMID: 16875810
-
[Emerging and drug-resistant infectious diseases--carbapenem resistant bacterial infections].Nihon Naika Gakkai Zasshi. 1997 Nov 10;86(11):2088-94. Nihon Naika Gakkai Zasshi. 1997. PMID: 9480315 Review. Japanese. No abstract available.
-
Class A carbapenemases.J Antimicrob Chemother. 2007 Sep;60(3):470-82. doi: 10.1093/jac/dkm226. Epub 2007 Jun 26. J Antimicrob Chemother. 2007. PMID: 17595289 Review.
Cited by
-
Structural and Functional Aspects of Class A Carbapenemases.Curr Drug Targets. 2016;17(9):1006-28. doi: 10.2174/1389450117666160310144501. Curr Drug Targets. 2016. PMID: 26960341 Free PMC article. Review.
-
Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales.Front Med (Lausanne). 2021 Jan 20;7:616490. doi: 10.3389/fmed.2020.616490. eCollection 2020. Front Med (Lausanne). 2021. PMID: 33553210 Free PMC article. Review.
-
Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia.J Thorac Dis. 2015 Mar;7(3):376-85. doi: 10.3978/j.issn.2072-1439.2014.12.33. J Thorac Dis. 2015. PMID: 25922715 Free PMC article.
-
Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.J Am Chem Soc. 2008 Sep 24;130(38):12656-62. doi: 10.1021/ja7111146. Epub 2008 Aug 30. J Am Chem Soc. 2008. PMID: 18761444 Free PMC article.
-
"Stormy waters ahead": global emergence of carbapenemases.Front Microbiol. 2013 Mar 14;4:48. doi: 10.3389/fmicb.2013.00048. eCollection 2013. Front Microbiol. 2013. PMID: 23504089 Free PMC article.
References
-
- Gales, A. C., D. J. Biedenbach, P. Winokur, D. M. Hacek, M. A. Pfaller, and R. N. Jones. 2001. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f β-lactamase (SME-1) in the United States: results from the MYSTIC Programme. Diagn. Microbiol. Infect. Dis. 39:125-127. - PubMed
-
- Jarlier, V., M.-H. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878. - PubMed
-
- Mollet, C., M. Drancourt, and D. Raoult. 1997. rpoB sequence analysis as a novel basis for bacterial identification. Mol. Microbiol. 26:1005-1011. - PubMed
-
- Naas, T., D. M. Livermore, and P. Nordmann. 1995. Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing β-lactamase Sme-1, and comparison of this regulator with other β-lactamase regulators. Antimicrob. Agents Chemother. 39:629-637. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
